Taking control of your global compliance ecosystem

At last year’s Pharma Compliance 2014 event, Greg Maynard, Director, Transparency and Disclosure Solutions, Health Market Science, gave a presentation “Taking control of your global compliance ecosystem.” Download and learn: Elements of a global transparency program Data Sourcing Data management Recipient profile data privacy data governing reporting Download Presentation Found this interesting? You might also be interested in our Pharma …

obstacles, global development, biosimilars

Regulatory provisions as facilitation and obstacles to global development of biosimilars

At the Biosimilar Drug Development World Europe event 2014, Andrea Laslop, AGES PharmMed gave a presentation on “Regulatory provisions as facilitation and obstacles to global development of biosimilars” Download and learn: Biosimilar regulation in EU Biosimilar regulation/approvals in other regions Joint approaches – the biosimilar “cluster“ Summary Download Presentation Found this interesting? Join us at next year’s Biosimilar Drug Development …

Financial, Forecast, Opportunity, Biosimilar, Medicine, Global, Healthcare, Marketplace

Financial Forecast: Opportunities For Biosimilar Medicines In The Global Healthcare Marketplace

At the Biosimilar Drug Development World Europe event 2014, Ashwin Pai, Jefferies International, gave a presentation on “Financial Forecast: Opportunities For Biosimilar Medicines In The Global Healthcare Marketplace.” Download and learn: Biosimilars – Where Do We Stand Today? What Does The Future Hold? Emerging Markets – Opportunity Large Than Previously Expected Developed Markets – Wide Differences Across Markets And Molecules What …

Download: Delivering effective training on compliance

Dr. Britta Luescher, Compliance Director, Novartis International AG, Switzerland gave a presentation at Pharma Compliance Europe 2013 on “Delivering effective training on compliance-Implementing a comprehensive training and monitoring system”. Download the presentation to learn: Delivering effective compliance training Training as part of a comprehensive compliance system What are the considerations for delivering effective compliance training? Consistency: Consider training as promoting a …

Challenges of Optimizing Drug Pricing in Emerging Markets

      By Arnaud Grunwald Globally, healthcare costs are coming under scrutiny like never before. Everywhere in the world – whether European countries, Canada, Australia and even emerging markets – more pharmaceutical products, medical devices and services are competing for fewer healthcare dollars while governments seek to alleviate economic pressure by imposing price controls and looking for ways to …

Utilizing Global Pricing Data and Advanced Analytics for Better Decisions and Competitor Edge

By Preeti Patel, VP, Consulting Increasing price transparency and global competition are key challenges faced by companies across all industries. Today’s pricing decisions cannot be based on instinct or informal methods due to the high level of risk incurred through inaccurate practices. Data and analytics have become powerful tools for pharmaceutical organizations in their strive to stay ahead of competitors. …

Ebook Download: How are Global Austerity Measures Impacting Pharma?

As we all know, various austerity measures have been announced since the global recession in 2008 and the Eurozone crisis in 2009 and are impacting everything, including the pharma industry. </> Download the ebook But how, specifically? We pose this question to several of our speakers from Evidence EU 2013 including: Sophie Murdoch, Alliance Life Sciences Brian Lovatt, Vision Healthcare …

Maneuvering in a dynamic global payer environment

Ed Schoonveld of ZS Associates offers an overview of recent changes and trends in the global payer environment. The Challenge The prescription drug landscape is changing in an unprecedented way. Economic recession related austerity measures and budget challenges motivate payers to act on long-standing concerns that incremental benefits for new drugs are often insufficiently substantiated at time of pricing and …

Top Trends in Global Market Access and Pricing

    Last year at Market Access World USA, Ed Schoonveld, Managing Principal, Market Access & Pricing Practice, ZS Associates gave a presentation covering the current issues and trends in global market access and pricing.  The global market access and pricing environment for drugs continues to evolve rapidly, especially due to the recession amplifying intensified payer scrutiny of drug value …